Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1997-8-6
|
pubmed:abstractText |
Disorders in which there is toxic buildup of circulating substrate may be treated by furnishing an enzyme reservoir capable of metabolically processing the excess substrate. The epidermal keratinocyte is a potential site for such a reservoir. In this study, we explore the capacity of genetically modified keratinocytes to metabolize extracellular substrate in a culture model that resembles in vivo epidermal architecture. Keratinocytes from adenosine deaminase (ADA)-deficient patients were transduced with a retroviral vector encoding the human ADA gene and the capacity of this tissue to deaminate deoxyadenosine (dAdo) in vitro was measured. The results show that at a substrate concentration of 10 microM, ADA-corrected keratinocytes deaminate dAdo at a rate of 0.38 nmol/min.10(6) cells. These results indicate that keratinocytes process extracellular substrate at rates that suggest complete substrate conversion in a single pass. This study provides a strong indication that the epidermis, the largest and most accessible tissue of the body, is a valuable site for designing clinically relevant gene therapies.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1043-0342
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
911-7
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:9195213-Adenosine Deaminase,
pubmed-meshheading:9195213-Cells, Cultured,
pubmed-meshheading:9195213-Child,
pubmed-meshheading:9195213-Gene Therapy,
pubmed-meshheading:9195213-Humans,
pubmed-meshheading:9195213-Keratinocytes,
pubmed-meshheading:9195213-Metabolic Diseases,
pubmed-meshheading:9195213-Retroviridae,
pubmed-meshheading:9195213-Transduction, Genetic
|
pubmed:year |
1997
|
pubmed:articleTitle |
Keratinocyte gene therapy for adenosine deaminase deficiency: a model approach for inherited metabolic disorders.
|
pubmed:affiliation |
Department of Oral Biology and Pathology, State University of New York at Stony Brook 11794, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.
|